Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Breast Cancer Research : BCR|May 15, 2024
Fusogenic vesicular stomatitis virus combined with natural killer T cell immunotherapy controls metastatic breast cancerAdam Nelson, Nichole McMullen, Simon Gebremeskel, et al.
Cancer Immunology Research|October 22, 2017
Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast CancerSimon Gebremeskel, Lynnea Lobert, Kaitlyn Tanner, et al.
Plastic and Reconstructive Surgery|December 28, 2018
Promotion of Primary Murine Breast Cancer Growth and Metastasis by Adipose-Derived Stem Cells Is Reduced in the Presence of Autologous Fat GraftSimon Gebremeskel, John Gencarelli, Alison J Gareau, et al.
Plastic and Reconstructive Surgery|July 29, 2015
Effect of N-Acetylcysteine on Adipose-Derived Stem Cell and Autologous Fat Graft Survival in a Mouse ModelJoshua Gillis, Simon Gebremeskel, Kyle D Phipps, et al.
Scientific Reports|August 10, 2020
Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomasBassel Dawod, Jinghua Liu, Simon Gebremeskel, et al.
Blood|July 5, 2012
Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopeniaRukhsana Aslam, Yu Hu, Simon Gebremeskel, et al.
Neuropharmacology|August 30, 2016
Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathyAnna-Maria Szczesniak, Richard F Porter, James T Toguri, et al.
Molecular Therapy Oncolytics|September 1, 2017
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor ModelsFabrice Le Boeuf, Simon Gebremeskel, Nichole McMullen, et al.
Acta Crystallographica. Section D, Biological Crystallography|October 8, 2014
Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2Wei Qiu, Robert Lam, Oleksandr Voytyuk, et al.
Frontiers in Immunology|February 14, 2022
The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon ActivationWouter Korver, Alan Wong, Simon Gebremeskel, et al.
Pageof 3